Individualized assessment of bleeding versus thrombosis risk is required for managing antithrombotic therapy during invasive procedures.
When patients receiving anticoagulation therapy undergo invasive procedures, management requires an individualized assessment of the risk of bleeding versus the risk of thrombosis. This review explains management, including bridging anticoagulation for patients receiving warfarin.
Baron et al. (Wed,) studied this question.